Loss of zfp36 expression in colorectal cancer correlates to wnt/ β-catenin activity and enhances epithelial-to-mesenchymal transition through upregulation of zeb1, sox9 and macc1

The mRNA-destabilizing protein ZFP36 has been previously described as a tumor suppressor whose expression is lost during colorectal cancer development. In order to evaluate its role in this disease, we restored ZFP36 expression in different cell contexts, showing that the presence of this protein im...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget 2016-09, Vol.7 (37), p.59144-59157
Main Authors: Montorsi, Lucia, Guizzetti, Filippo, Alecci, Claudia, Caporali, Andrea, Martello, Andrea, Atene, Claudio Giacinto, Parenti, Sandra, Pizzini, Silvia, Zanovello, Paola, Bortoluzzi, Stefania, Ferrari, Sergio, Grande, Alexis, Zanocco-Marani, Tommaso
Format: Article
Language:English
Subjects:
Research Paper
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The mRNA-destabilizing protein ZFP36 has been previously described as a tumor suppressor whose expression is lost during colorectal cancer development. In order to evaluate its role in this disease, we restored ZFP36 expression in different cell contexts, showing that the presence of this protein impairs the epithelial-to-mesenchymal transition (EMT) and induces a higher susceptibility to anoikis. Consistently, we found that ZFP36 inhibits the expression of three key transcription factors involved in EMT: ZEB1, MACC1 and SOX9. Finally, we observed for the first time that its expression negatively correlates with the activity of Wnt/β-catenin pathway, which is constitutively activated in colorectal cancer. This evidence provides a clue on the mechanism leading to the loss of ZFP36 in CRC.
ISSN:1949-2553
1949-2553
DOI:10.18632/oncotarget.10828